Trial | NCT04780386  Report issue

Title

Compare the Pharmacokinetics of NVP-1805 and Coadministration of NVP-1805-R1 With NVP-1805-R2
A Clinical Trial to Compare the Pharmacokinetics and Safety of NVP-1805 and Coadministration of NVP-1805-R1 With NVP-1805-R2 in Healthy Male Volunteers

  • Phase

    Phase 1

  • Study Type

    Interventional

  • Status

    Completed No Results Posted

  • Study Participants

    58
The purpose of this study is to compare the pharmacokinetics of NVP-1805 and coadministration of NVP-1805-R1 with NVP-1805-R2.
pharmacokinetics and safety of NVP-1805 compared to coadministration of NVP-1805-R1 with NVP-1805-R2
Study Started
Aug 29
2020
Primary Completion
Nov 02
2020
Study Completion
Feb 16
2021
Last Update
Mar 03
2021

Drug NVP-1805

orally, once daily on Period 1 and Period 3 (or Period 2 and Period 4)

Drug NVP-1805-R1and NVP-1805-R2

orally, once daily on Period 1 or Period 3 (or Period 2 and Period 4)

NVP-1805 Experimental

NVP-1805

NVP-1805-R1 and NVP-1805-R2 Active Comparator

coadministration of NVP-1805-R1 and NVP-1805-R2

Criteria 

Inclusion Criteria:

Healthy adult subjects who signed informed consent
BMI of >18.0 kg/㎡ and <30.0 kg/㎡ subject, weight more than 50kg(45 kg or more for woman)

Exclusion Criteria:

Subjects participated in another clinical trial within 6 months prior to administration of the study drug
Inadequate subject for the clinical trial by the investigator's decision
Subjects participated in another clinical trial within 6 months prior to administration of the study drug
No Results Posted